Lista de obras -

Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET.

artículo científico publicado en 2017

Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairment

artículo científico publicado en 2011

Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease

artículo científico publicado en 2011

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease

artículo científico publicado en 2006

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

artículo científico publicado en 2002

Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231.

artículo científico publicado en 2003

Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease

artículo científico publicado en 2006

Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease

artículo científico publicado en 2010

Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease

artículo científico publicado en 2011

Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's disease

artículo científico publicado en 2011

Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study

artículo científico publicado en 2011

Functional representation of olfactory impairment in early Alzheimer's disease

artículo científico publicado en 2010

Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease

artículo científico publicado en 2002

Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls

artículo científico publicado en 2012

Increased CSF-BACE1 activity associated with decreased hippocampus volume in Alzheimer's disease

artículo científico publicado en 2011

Increased levels of CSF phosphorylated tau in apolipoprotein E epsilon4 carriers with mild cognitive impairment

artículo científico publicado en 2005

Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial

artículo científico publicado en 2013

Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease

artículo científico publicado en 2018

Long-term observation of a multicomponent cognitive intervention in mild cognitive impairment

artículo científico

Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients

artículo científico publicado en 2003

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study

artículo científico publicado en 2004

Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies

artículo científico publicado en 2019

Neuronal correlates of serial position performance in amnestic mild cognitive impairment

artículo científico publicado en 2016

Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease

artículo científico publicado en 2019

Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease

artículo científico

Pharmacological treatment of Alzheimer's dementia: state of the art and current dilemmas

artículo científico publicado en 2008

Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild cognitive impairment

artículo científico publicado en 2010

Prevalence of Amyloid Positron Emission Tomographic Positivity in Poststroke Mild Cognitive Impairment

artículo científico

Real-space navigation testing differentiates between amyloid-positive and -negative aMCI

artículo científico publicado en 2020

Reliable manual segmentation of the frontal, parietal, temporal, and occipital lobes on magnetic resonance images of healthy subjects

artículo científico publicado en 2005

The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease

scientific article published on 21 March 2019

Lista de obras de

Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET.

Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairment

Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231.

Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease

Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease

Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease

Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's disease

Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study

Functional representation of olfactory impairment in early Alzheimer's disease

Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease

Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls

Increased CSF-BACE1 activity associated with decreased hippocampus volume in Alzheimer's disease

Increased levels of CSF phosphorylated tau in apolipoprotein E epsilon4 carriers with mild cognitive impairment

Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial

Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease

Long-term observation of a multicomponent cognitive intervention in mild cognitive impairment

Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study

Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies

Neuronal correlates of serial position performance in amnestic mild cognitive impairment

Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease

Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease

Pharmacological treatment of Alzheimer's dementia: state of the art and current dilemmas

Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild cognitive impairment

Prevalence of Amyloid Positron Emission Tomographic Positivity in Poststroke Mild Cognitive Impairment

Real-space navigation testing differentiates between amyloid-positive and -negative aMCI

Reliable manual segmentation of the frontal, parietal, temporal, and occipital lobes on magnetic resonance images of healthy subjects

The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease